Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haina Qin

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Plos One|July 21, 2012
VAPC, an human endogenous inhibitor for hepatitis C virus (HCV) infection, is intrinsically unstructured but forms a "fuzzy complex" with HCV NS5BShaveta Goyal, Garvita Gupta, Haina Qin, et al.
The Biochemical Journal|April 12, 2012
Distinctive binding of three antagonistic peptides to the ephrin-binding pocket of the EphA4 receptorIlaria Lamberto, Haina Qin, Roberta Noberini, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2014
Disruption of FAT10-MAD2 binding inhibits tumor progressionSteven Setiawan Theng, Wei Wang, Way-Champ Mah, et al.
Chemical Biology & Drug Design|July 28, 2011
A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptorsRoberta Noberini, Surya K De, Ziming Zhang, et al.
Plos One|August 24, 2012
A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivoAaron Petty, Eugene Myshkin, Haina Qin, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Plos One|July 21, 2012
VAPC, an human endogenous inhibitor for hepatitis C virus (HCV) infection, is intrinsically unstructured but forms a "fuzzy complex" with HCV NS5BShaveta Goyal, Garvita Gupta, Haina Qin, et al.
The Biochemical Journal|April 12, 2012
Distinctive binding of three antagonistic peptides to the ephrin-binding pocket of the EphA4 receptorIlaria Lamberto, Haina Qin, Roberta Noberini, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2014
Disruption of FAT10-MAD2 binding inhibits tumor progressionSteven Setiawan Theng, Wei Wang, Way-Champ Mah, et al.
Chemical Biology & Drug Design|July 28, 2011
A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptorsRoberta Noberini, Surya K De, Ziming Zhang, et al.
Plos One|August 24, 2012
A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivoAaron Petty, Eugene Myshkin, Haina Qin, et al.
Pageof 3